Abstract: Mixtures of catenate and cyclic siloxane oligomers of formula I and II ##STR1## wherein the substituents R consist of 3-methacryloxypropyl or 3-acryloxypropyl groups and methoxy, ethoxy and/or propoxy groups alone or together with C.sub.1 -C.sub.18 alkyl, fluoroalkyl, isoalkyl or cycloalkyl groups and/or C.sub.6 -C.sub.12 aryl groups and where not more than one 3-methacryloxypropyl or 3-acryloxypropyl group is attached to one silicon atom and the degree of oligomerization of compounds of the formula I is within the range 2<m<25 and of compounds of the formula II is within the range 2<n<8 and the quotient of the molar proportion of Si/alkoxy groups is .gtoreq.0.5.

Abstract: 3-Pyrroline-2-carboxylic acid derivatives of the formula I ##STR1## are prepared by eliminating the sulfonic acid residue, with the aid of a base, from a compound of the formula II ##STR2##

Abstract: Compounds of the formula ##STR1## where A, B, E and D have the meanings indicated in the description, and their preparation are described. The substances are suitable for controlling diseases.

Abstract: The residual halogen content in alkoxysilanes and in alkoxysilane-based compositions is reduced by a process comprising, treating the alkoxysilane or the alkoxysilane-based composition with activated carbon.

Abstract: Organopolysiloxane containing compositions are prepared by mixing an organopolysiloxane containing an aminoalkyl group, an organopolysiloxane containing a fluoroalkyl group, and optionally, organopolysiloxanes containing alkyl groups, together with water, or a water/acid mixture, or a water/acid/alcohol mixture, where the mixture is adjusted to have a pH in the range of 1-8, then removing the alcohol already present or formed during reaction.

Abstract: Compounds of the formula ##STR1## where A, B, D, R.sup.1 and R.sup.2 have the meanings stated in the description, are described. The compounds are suitable for controlling diseases.The novel compounds are prepared via compounds of the formulaH.sub.2 N--CH.sub.

Abstract: Thrombin inhibitors of the formula ##STR1## where R.sup.1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described.The compounds I are suitable for controlling diseases.

Abstract: Organopolysiloxane-containing, water-based compositions which are essentially free from organic solvents, have a flash point of above 70.degree. C. and liberate essentially no alcohols through hydrolysis on dilution with water, and which contain, as functional groups, glycidyl ether alkyl, acryloxyalkyl and/or methacryloxyalkyl groups, where each silicon in the organopolysiloxane carries one functional group, as well to a process for the preparation of such organopolysiloxane-containing compositions and to their use.

Abstract: An aqueous alcoholic fluoroalkyl functional group containing organopolysiloxane-composition, comprising:organopolysiloxanes of formula I:RO?Si(A)(CH.sub.3).sub.z (OR).sub.1-z O!.sub.a ?Si(B)(R.sup.2).sub.y (OR).sub.1-y O!.sub.b ?Si(C)(CH.sub.3)O!.sub.c ?Si(D)(OR)O!.sub.d R.multidot.(HX) (I)wherein A is an aminoalkyl radical derived from the compound of formula II:H.sub.2 N(CH.sub.2).sub.f (NH).sub.g (CH.sub.2).sub.h Si(OR).sub.3-z (CH.sub.3).sub.z (II)wherein 0.ltoreq.f.ltoreq.6, 9=0 if f=0 and g=1 if f>0, 0.ltoreq.h.ltoreq.6 and 0.ltoreq.z.ltoreq.1, and B is a fluoroalkyl radical derived from the compound of formula III:R.sup.1 --Y--(CH.sub.2).sub.2 Si(R.sup.2).sub.y (OR).sub.3-y (III)wherein R.sup.1 is a mono-, oligo- or perfluorinated alkyl group having 1-9 C atoms or a mono-, oligo- or perfluorinated aryl group, Y is a CH.sub.2, O or S group, R.sub.2 is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group and 0.ltoreq.y.ltoreq.

Abstract: Compounds of the formula I ##STR1## in which R.sup.1, A and B have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases.

Abstract: An aqueous alcoholic fluoroalkyl functional group containing organopolysiloxane- composition, comprising:organopolysiloxanes of formula I:RO?Si(A)(CH.sub.3).sub.z (OR).sub.1-z O!.sub.a ?Si(B)(R.sup.2).sub.y (OR).sub.1-y O!.sub.b?Si(C)(CH.sub.3)O!.sub.c ?Si(D)(OR)O!.sub.d R.multidot.(HX)(I)wherein A is an aminoalkyl radical derived from the compound of formula II:H.sub.2 N(CH.sub.2).sub.f (NH).sub.g (CH.sub.2).sub.h Si(OR).sub.3-z (CH.sub.3).sub.z (II)wherein 0.ltoreq.f.ltoreq.6, 9=0 if f=0 and g=1 if f>0, 0.ltoreq.h.ltoreq.6 and 0.ltoreq.z.ltoreq.1, and B is a fluoroalkyl radical derived from the compound of formula III:R.sup.1 --Y--(CH.sub.2).sub.2 Si(R.sup.2)y(OR).sub.3-y (III)wherein R.sup.1 is a mono-, oligo- or perfluorinated alkyl group having 1-9 C atoms or a mono-, oligo- or perfluorinated aryl group, Y is a CH.sub.2, O or S group, R.sub.2 is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group and 0.ltoreq.y.ltoreq.

Abstract: An aqueous organopolysiloxane-containing composition comprising organopolysiloxanes of formula I:HO?Si(A) (CH.sub.3).sub.z (OH).sub.1-z O!.sub.a ?Si(B) (R.sup.2).sub.y (OH).sub.1-y O!.sub.b ?Si(C) (CH.sub.3)O!.sub.c ?Si(D) (OH)O!.sub.d H.multidot.(HX).sub.e (I),wherein A is an aminoalkyl group of formula II:H.sub.2 N(CH.sub.2).sub.f (NH).sub.g (CH.sub.2).sub.h Si(OR).sub.3-z (CH.sub.3).sub.z (II),in which 0.ltorsim.f.ltorsim.6, g=0 if f=0 and g=1 if f>0, 0.ltorsim.h.ltorsim.6 and 0.ltorsim.z.ltorsim.1;B is a fluoroalkyl group of formula III:R.sup.1 --Y--(CH.sub.2).sub.2 Si(R.sup.2)y(OR).sub.3-y (III),wherein R.sup.1 is a mono-, oligo- or perfluorinated alkyl group having 1-9 C atoms, or a mono-, oligo- or perfluorinated aryl group, Y is a CH.sub.2, O or S group, R.sup.2 is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group and 0.ltorsim.y.ltorsim.1;C is an alkyl group of formula IV:R.sup.3 --Si(CH.sub.3) (OR).sub.2 (IV),and D is an alkyl group of formula V:R.sup.3 --Si(OR).sub.

Abstract: 2-Substituted 3-(4-amidinophenyl)propionic acid derivatives of the formula ##STR1## in which A, Ar and B have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.